Diligent Pharma

Driving Innovation Together: Diligent Pharma x GenVault   We’re thrilled to announce our collaboration with GenVault, a provider of bioinventory storage solutions and lab transport services.   By leveraging GenVault's Qualification Package on the Diligent Platform, clients can now qualify GenVault in just days. GenVault continues to innovate to drive efficiency—helping clients save time, streamline resources, and accelerate their onboarding processes. Diligent supports GenVault's mission to give its clients more time to focus on innovation.   Discover how Diligent Pharma and GenVault are shaping the future of vendor qualification and how to access the GenVault Qualification Package today. 🔗 Learn more: https://lnkd.in/dAcA8gij   #Innovation #VendorQualification #ClinicalTrials #DiligentPharma #GenVault #StreamlinedProcesses #PharmaInnovation #FutureOfClinicalTrials #LifeSciences

Exceeding expectations and delivering value. Our partner Cerevel shares how our consistent assessment criteria and cost-effective audit process have made a real difference to their vendor qualification process. Read the full success story here to learn more: https://lnkd.in/d3AsqiB2 #DiligentPharma #VendorQualification #SuccessStory

At Diligent Pharma, our quality experts are always at the forefront of regulatory, quality/compliance, and clinical trial industry developments. We're excited to launch Staying Diligent – a curated series of key updates to keep you informed.   Stay tuned for more industry insights!   Sources: - FDA Announces 7 New Clinical Trial Grants under the Orphan Product Grants Program (fda.gov, Oct 1, 2024) - MHRA launches Strategy for Improving Safety Communications on World Patient Safety Day (www.gov.uk, 17 Sep 2024) - FDA Issues Final Guidance Document on Conducting Clinical Trials With Decentralized Elements (FDA.gov, September 2024)   #RegulatoryAffairs #PharmaceuticalIndustry #ClinicalTrials #QualityCompliance #FDA #MHRA #OrphanDrugs #PatientSafety #DecentralizedTrials #PharmaQuality #DrugDevelopment #LifeSciences #BioPharma #RegulatoryIntelligence #PharmaTech #HealthcareInnovation #MedicalResearch #DrugSafety #PharmaNews #RegulatoryStrategy

Attention Clinical Trial Service Providers!   Imagine a world where you only need to host one vendor qualification audit per year. Sounds too good to be true? At Diligent Pharma, we can make that a reality.   Curious how? Let us show you.   Connect with us today to learn more! www.DiligentPharma.com   #ClinicalTrials #Pharma #VendorManagement #AuditEfficiency #DiligentPharma

We’re excited to share how Eli Lilly and Company is leveraging the Diligent Platform to streamline their vendor qualification processes. Our collaboration is setting a new standard for process innovation in the industry, helping to reduce redundancies and alleviate the resource strain associated with vendor qualification.   Swipe through to discover how we’re shaping the future of vendor qualification and management. #VendorQualification #Innovation #Efficiency #EliLilly #DiligentPharma #ClinicalTrials

Another insightful and energizing #DPHARM event in the books! Thank you to all who came out to hear about Diligent Pharma’s growing partnership with Eli Lilly. We’re thrilled to be teaming up with such an industry powerhouse to break the inefficiencies that exist in the current vendor qualification process.   Innovation is upon us. We can’t be afraid of change. We must shorten trial start-up times. We need to reconsider the status quo, imagine the possibilities of the future, and know we have the current way of working to fall back on.   It was refreshing to hear the industry echo the same points we preach at Diligent Pharma.   Come try us out. What do you have to lose? #Innovation #Efficiency #ClinicalTrials #DPharm2024 #EliLilly #VendorQualification #Partnership

We’re excited to be heading to OCT Southern California next week! Join us in San Diego for two days of insights, innovation, and collaboration! We’re thrilled to have Anthea Dransfield, Diligent Pharma’s Head of Quality, present on how a risk-based, data-driven approach to vendor qualification can drastically reduce clinical trial start-up times.   Diligent Pharma: Streamlining Vendor Qualification to Accelerate Trial Start-Up 🗓️ Tuesday, September 24 🕓 4:10 PM   Don't miss this chance to learn how Diligent’s centralized, tech-enabled process efficiency is reshaping vendor management practices.   Let’s connect—come by Booth #63 or reach out to schedule a meeting with our experts. See you in San Diego!   #OCTSouthernCalifornia #ClinicalTrials #VendorManagement #ClinicalOperations #PharmaInnovation

Meet Nicos Zittis.   Nicos manages Regeneron’s Vendor Relationships and felt the challenge of managing multiple vendor qualifications with tight deadlines and limited resources. From preparing extensive questionnaires to dealing with incomplete responses from Vendors, their team faced hurdles that slowed down the onboarding processes. It was clear the industry standard for qualification didn’t cut it anymore. Enter Diligent Pharma.  With access to a comprehensive database of risk-scored qualification data (RFIs and audit reports), Diligent Pharma helped Regeneron cut down their vendor qualification timelines by 2-3 weeks. Swipe through to discover how Nicos streamlined Regeneron's qualification process. #VendorQualification #Innovation #Efficiency #ClinicalTrials

Exciting times ahead! This Fall, we look forward to bringing our expertise in clinical trials, vendor qualification, and risk management to a series of industry-leading events. Our team will be on stage at each event discussing the future of clinical research and how we can drive progress in vendor management through our process innovation. 👉 Check out the full schedule to see where we’ll be presenting and engaging with the industry! https://lnkd.in/dmVUVz4s We’d love to connect with you. Whether you're attending these events or just interested in learning more about Diligent Pharma, please reach out to us to explore opportunities to collaborate. 🌟 info@DiligentPharma.com #ClinicalTrials #Innovation #VendorQualification #RiskManagement #IndustryEvents

🚀 We're thrilled to be speaking at #DPharm2024 on how our partnership with Eli Lilly is transforming vendor management in clinical trials. Join Kenneth Olovich, Executive Director of Sourcing, Procurement and Finance, Chorus Division, Eli Lilly and Patricia Leuchten, Founder and CEO of Diligent Pharma, as we discuss an innovative approach to vendor management that reduces the inefficiencies inherent in current processes and helps speed-up clinical trial start-up times for the benefit of patients. Don't miss our session, "Diligent Pharma and Eli Lilly: Accelerating Trial Startup and Reducing Vendor Management Burden Through a Centralized Model," and learn how the Diligent centralized quality and risk management platform is driving smarter, data-driven decision-making in clinical trials. 📅 Tuesday, September 17, 2024, 4:10 PM at DPHARM: Disruptive Innovations to Modernize Clinical Research 💬 We look forward to connecting with you at the show! #ClinicalTrials #VendorManagement #PharmaInnovation #RegulatoryCompliance #PatientFirst #DiligentPharma #EliLilly